Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo
Dengue, a significant public health problem in several countries around the world, is caused by four different serotypes of mosquito-borne dengue viruses (DENV-1, -2, -3, and -4). Antibodies to any one DENV serotype which can protect against homotypic re-infection, do not offer heterotypic cross-pro...
Main Authors: | Rahul Shukla, Ravi K. Rajpoot, Upasana Arora, Ankur Poddar, Sathyamangalam Swaminathan, Navin Khanna |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fmicb.2017.02644/full |
Similar Items
-
Pichia pastoris-expressed Dengue 3 Envelope-based Virus-like Particles Elicit Predominantly Domain III-Focused High Titer Neutralizing Antibodies
by: Lav eTripathi, et al.
Published: (2015-09-01) -
Efficient production of human bivalent and trivalent anti-MUC1 Fab-scFv antibodies in <it>Pichia pastoris</it>
by: Haustraete Jurgen, et al.
Published: (2009-08-01) -
Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.
by: Shailendra Mani, et al.
Published: (2013-01-01) -
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine
by: Rahul Shukla, et al.
Published: (2020-10-01) -
Dengue vaccine development: Global and Indian scenarios
by: Sathyamangalam Swaminathan, et al.
Published: (2019-07-01)